nature.com search

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

nature
search

Search My Account Login

advanced

where the list of authors contains where the title contains

Refine your results by…

volume

start page / article no.

Filters

Filter By:

Article type

Check one or more article types to show results from those article types only.

Research (3)

Journal

Check one or more journals to show results from those journals only.

Leukemia (14)

Choose more journals

Subject Check one or more subjects to show results from those subjects only.

Anaemia (1)
Cancer (1)
Chemotherapy (1)
Erythropoietin (1)
Medical research (1)

Date

Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
In the last year
Last 2 years
Last 5 years

Custom date range

Sort by Relevance

Choose a way to sort results.

Relevance
Date — most recent
Date — oldest first

Loading Filters

Showing 1–14 of 14 results

Loading Filters

3 August 2017 | Open
Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results
- T P Hughes
- , B Leber
- , F Cervantes
- , N Spector
- , R Pasquini
- , N C D Clementino
- , A P Schwarer
- , P E Dorlhiac-Llacer
- , F-X Mahon
- , D Rea
- , A Guerci-Bresler
- , S Kamel-Reid
- , I Bendit
- , S Acharya
- , T Glynos
- , D Dalal
- , S Branford
- & J H Lipton
Leukemia 31 , 2529–2531

Rights & permissionsfor article Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results . Opens in a new window.
18 February 2003
Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL) with low white blood cell counts: results from APL 93 trial
- S de Botton
- , S Chevret
- , V Coiteux
- , H Dombret
- , M Sanz
- , J San Miguel
- , D Caillot
- , A Vekhoff
- , M Gardembas
- , A Stamatoulas
- , E Conde
- , A Guerci
- , C Gardin
- , M Fey
- , D Cony Makhoul
- , O Reman
- , J de la Serna
- , F Lefrere
- , C Chomienne
- , L Degos
- & P Fenaux
Leukemia 17 , 339–342

Rights & permissionsfor article Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL) with low white blood cell counts: results from APL 93 trial . Opens in a new window.
6 June 2000
Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation
- X Thomas
- , H Dombret
- , C Cordonnier
- , A Pigneux
- , C Gardin
- , A Guerci
- , A Vekhoff
- , A Sadoun
- , A Stamatoullas
- , N Fegueux
- , F Maloisel
- , JY Cahn
- , O Reman
- , N Gratecos
- , C Berthou
- , F Huguet
- , P Kotoucek
- , P Travade
- , A Buzyn
- , T de Revel
- , JP Vilque
- , P Naccache
- , C Chomienne
- , L Degos
- & P Fenaux
Leukemia 14 , 1006–1013

Rights & permissionsfor article Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation . Opens in a new window.
16 April 1999
A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes
- E Wattel
- , E Solary
- , X Leleu
- , F Dreyfus
- , A Brion
- , JP Jouet
- , L Hoang-Ngoc
- , F Maloisel
- , A Guerci
- , H Rochant
- , N Gratecos
- , P Casassus
- , M Janvier
- , P Brice
- , P Lepelley
- & P Fenaux
Leukemia 13 , 524–529

Rights & permissionsfor article A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes . Opens in a new window.
Research | 8 January 2009
Is there a role for all-trans retinoic acid in combination with recombinant erythropoetin in myelodysplastic syndromes? A report on 59 cases
- R Itzykson
- , S Ayari
- , D Vassilief
- , E Berger
- , B Slama
- , N Vey
- , F Suarez
- , O Beyne-Rauzy
- , A Guerci
- , S Cheze
- , X Thomas
- , A Stamatoullas
- , M Gardembas
- , F Bauduer
- , A Kolb
- , M C Chaury
- , L Legros
- , G Damaj
- , F Chermat
- , F Dreyfus
- , P Fenaux
- & L Ades
Leukemia 23 , 673–678

Rights & permissionsfor article Is there a role for all-trans retinoic acid in combination with recombinant erythropoetin in myelodysplastic syndromes? A report on 59 cases . Opens in a new window.
16 March 2006
Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline- based chemotherapy: the European APL group experience (APL 91 and APL 93 trials)
- C Kelaidi
- , L Ades
- , S Chevret
- , M Sanz
- , A Guerci
- , X Thomas
- , S de Botton
- , E Raffoux
- , C Rayon
- , N Fegueux
- , D Bordessoule
- , F Rigal-Huguet
- , H Link
- , A Stoppa
- , A Vekhoff
- , S Meyer-Monard
- , S Castaigne
- , H Dombret
- , L Degos
- & P Fenaux
Leukemia 20 , 905–907

Rights & permissionsfor article Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline- based chemotherapy: the European APL group experience (APL 91 and APL 93 trials) . Opens in a new window.
4 August 2000
Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia
- P Fenaux
- , S Chevret
- , A Guerci
- , N Fegueux
- , H Dombret
- , X Thomas
- , M Sanz
- , H Link
- , F Maloisel
- , C Gardin
- , D Bordessoule
- , A-M Stoppa
- , A Sadoun
- , P Muus
- , H Wandt
- , P Mineur
- , JA Whittaker
- , M Fey
- , M-T Daniel
- , S Castaigne
- & L Degos
Leukemia 14 , 1371–1377

Rights & permissionsfor article Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia . Opens in a new window.
8 November 2011
SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications
- F Damm
- , F Thol
- , O Kosmider
- , S Kade
- , P Löffeld
- , F Dreyfus
- , A Stamatoullas-Bastard
- , A Tanguy-Schmidt
- , O Beyne-Rauzy
- , S de Botton
- , A Guerci-Bresler
- , G Göhring
- , B Schlegelberger
- , A Ganser
- , O A Bernard
- , M Fontenay
- & M Heuser
Leukemia 26 , 1137–1140

Rights & permissionsfor article SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications . Opens in a new window.
16 April 2002
Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon α-2b for the treatment of chronic myelogenous leukemia patients in chronic phase
- F Maloisel
- , A Guerci
- , D Guyotat
- , N Ifrah
- , M Michallet
- , J Reiffers
- , G Tertain
- , M Blanc
- , F Bauduer
- , J Brière
- , JF Abgrall
- , B Pegourie-Bandelier
- , E Solary
- , N Cambier
- , D Coso
- , JP Vilque
- , M Delain
- , JL Harousseau
- , P Rousselot
- , K Belhadj
- , P Morice
- , J Attal
- , M Chabin
- , C Chastang
- , J Guilhot
- & F Guilhot
Leukemia 16 , 573–580

Rights & permissionsfor article Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon α-2b for the treatment of chronic myelogenous leukemia patients in chronic phase . Opens in a new window.
25 November 2004
Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience
- L Ades
- , S Chevret
- , S De Botton
- , X Thomas
- , H Dombret
- , B Beve
- , M Sanz
- , A Guerci
- , J S Miguel
- , J dela Serna
- , C Garo
- , A M Stoppa
- , O Reman
- , A Stamatoulas
- , M Fey
- , J Y Cahn
- , J J Sotto
- , J H Bourhis
- , A Parry
- , C Chomienne
- , L Degos
- & P Fenaux
Leukemia 19 , 230–233

Rights & permissionsfor article Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience . Opens in a new window.
Research | 24 November 2005
Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy
- S de Botton
- , M A Sanz
- , S Chevret
- , H Dombret
- , G Martin
- , X Thomas
- , J D Mediavilla
- , C Recher
- , L Ades
- , B Quesnel
- , P Brault
- , M Fey
- , H Wandt
- , D Machover
- , A Guerci
- , F Maloisel
- , A M Stoppa
- , C Rayon
- , J M Ribera
- , C Chomienne
- , L Degos
- & P Fenaux
Leukemia 20 , 35–41

Rights & permissionsfor article Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy . Opens in a new window.
18 February 2003
Phase II trial of CPT-11 in myelodysplastic syndromes with excess of marrow blasts
- V Ribrag
- , F Suzan
- , C Ravoet
- , W Feremans
- , A Guerci
- , F Dreyfus
- , G Damaj
- , J M Vantelon
- , J H Bourhis
- & P Fenaux
Leukemia 17 , 319–322

Rights & permissionsfor article Phase II trial of CPT-11 in myelodysplastic syndromes with excess of marrow blasts . Opens in a new window.
12 May 2005
Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group
- C Callens
- , S Chevret
- , J-M Cayuela
- , B Cassinat
- , E Raffoux
- , S de Botton
- , X Thomas
- , A Guerci
- , N Fegueux
- , A Pigneux
- , A-M Stoppa
- , T Lamy
- , F Rigal-Huguet
- , A Vekhoff
- , S Meyer-Monard
- , A Ferrand
- , M Sanz
- , C Chomienne
- , P Fenaux
- & H Dombret
Leukemia 19 , 1153–1160

Rights & permissionsfor article Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group . Opens in a new window.
Research | 26 October 2015
Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion
- A Toma
- , O Kosmider
- , S Chevret
- , J Delaunay
- , A Stamatoullas
- , C Rose
- , O Beyne-Rauzy
- , A Banos
- , A Guerci-Bresler
- , S Wickenhauser
- , D Caillot
- , K Laribi
- , B De Renzis
- , D Bordessoule
- , C Gardin
- , B Slama
- , L Sanhes
- , B Gruson
- , P Cony-Makhoul
- , B Chouffi
- , C Salanoubat
- , R Benramdane
- , L Legros
- , E Wattel
- , G Tertian
- , K Bouabdallah
- , F Guilhot
- , A L Taksin
- , S Cheze
- , K Maloum
- , S Nimuboma
- , C Soussain
- , F Isnard
- , E Gyan
- , R Petit
- , J Lejeune
- , V Sardnal
- , A Renneville
- , C Preudhomme
- , M Fontenay
- , P Fenaux
- & F Dreyfus
Leukemia 30 , 897–905

Rights & permissionsfor article Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion . Opens in a new window.

Nature Research menu

Our Journals

Nature
Nature Communications
Nature Protocols
Scientific Reports
View all journals

Subjects

Biological Sciences
Scientific Community & Society
Earth & Environmental Sciences
Health Sciences
Physical Sciences
View all subjects

Contact us
Authors & Referees
Librarians
Advertisers
Press
About Nature Research

Search

Article search

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

nature.com sitemap

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
Nano
Protocol Exchange
Nature Index

Publish with us

Guide to Authors
Guide to Referees
Editorial policies
Open access
Reprints & permissions

Researcher services

Research data
Language editing
Scientific editing
Nature Masterclasses
Nature Research Academies

Libraries & institutions

Librarian service & tools
Librarian portal
Open research

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Career development

Nature Careers
Nature Conferences
Nature events

Regional websites

Nature China
Nature India
Nature Japan
Nature Korea
Nature Middle East

Refine your results by…

Filters ​

Filter By:

Search

Quick links

Filters